MNGI Digestive Health (MNGI) annually tracks and reports on key Colonoscopy Quality Measures for their gastroenterologists. The 2023 Adenoma Detection Rate (ADR) data from MNGI has been released, showcasing their physicians’ proficiency in locating and removing precancerous polyps during screening colonoscopies.
The results are notably impressive. MNGI gastroenterologists’ ADR performance significantly surpasses the performance targets set by the American Society for Gastrointestinal Endoscopy (ASGE). Specifically, their ADR is more than double the national benchmark for male patients and nearly triple for female patients.
This high ADR performance indicates that colonoscopies performed by MNGI providers substantially reduce the risk of developing colorectal cancer in the next 5-10 years, compared to results from other providers.